Published in Drug Week, September 10th, 2004
"The EFRH sequence, found to be the main anti-aggregating epitope corresponding to amino acids 3-6 of beta-amyloid peptide (A-betaP), was displayed on a phage and used as an antigen for immunization of mice, guinea pigs, and rabbits. The generated antibodies recognize the full-length A-betaP (1-40) and exhibit similar biological properties to antibodies raised against whole soluble peptide and/or fibrillar beta-amyloid," investigators in Israel report.
"EFRH-phage immunization of a transgenic mouse model of Alzheimer's disease evokes antibodies able to dissolve...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.